IntegriChain Announces Close of Nordic Capital Majority Investment
PHILADELPHIA, Dec. 19, 2023 /PRNewswire/ -- IntegriChain today announced the close of an investment agreement whereby Nordic Capital has acquired the majority stake in IntegriChain. IntegriChain's integrated ICyte Platform helps pharma manufacturers connect the commercial, financial, and operational dimensions of drug commercialization, access, and profitability. Nordic Capital, a leading sector-specialized private equity investor with a broad portfolio in Healthcare and Pharma, acquired the majority stake from Accel-KKR, a global software private equity firm, which first invested in IntegriChain in 2016.
- PHILADELPHIA, Dec. 19, 2023 /PRNewswire/ -- IntegriChain today announced the close of an investment agreement whereby Nordic Capital has acquired the majority stake in IntegriChain.
- IntegriChain's integrated ICyte Platform helps pharma manufacturers connect the commercial, financial, and operational dimensions of drug commercialization, access, and profitability.
- Nordic Capital, a leading sector-specialized private equity investor with a broad portfolio in Healthcare and Pharma, acquired the majority stake from Accel-KKR, a global software private equity firm, which first invested in IntegriChain in 2016.
- Nordic Capital has unique experience at the crossroads of Pharma, healthcare technology, and payments technology.